advertisement
advertisement

GlaxoSmithKline to pay $20 million fine over bribing of foreign officials 

Pharma giant GlaxoSmithKline agreed to pay $20 million to the U.S. Securities and Exchange Commission after an investigation into whether a Chinese subsidiary bribed foreign officials in the form of gifts and travel to increase product sales.  The company didn’t confirm or deny the findings, but agreed to provide status reports to the SEC for … Continue reading “GlaxoSmithKline to pay $20 million fine over bribing of foreign officials “

advertisement
advertisement

Pharma giant GlaxoSmithKline agreed to pay $20 million to the U.S. Securities and Exchange Commission after an investigation into whether a Chinese subsidiary bribed foreign officials in the form of gifts and travel to increase product sales. 

advertisement

The company didn’t confirm or deny the findings, but agreed to provide status reports to the SEC for the next two years. 

About the author

Christina Farr is a San Francisco-based journalist specializing in health and technology. Before joining Fast Company, Christina worked as a reporter for VentureBeat, Reuters and KQED

More